Sarasota scientists have made a discovery that may pave the way for more effective drug therapies to treat Alzheimer’s patients in the future. In a study published in the Journal of Biological Chemistry, the Roskamp Institute’s scientists say they have isolated a single enzyme connected to all three key factors in Alzheimer’s disease – accumulation of amyloid protein, inflammation and modulation of the “tau” protein. All three damage nerve cells in the brain. “These studies suggest there is a single drug target to inhibit all three key pathologies of Alzheimer’s disease,” stated the study’s lead researcher, neurobiologist Daniel Paris, in...